Ms. Genesis Marte is a Bronx, New York based nurse practitioner. Active license number of Ms. Genesis Marte is 357253 for Family in New York. Her current practice location is 3548 Tryon Ave, Bronx. Patients can reach her at 347-453-7672. Ms. Genesis Marte is RN and her NPI number (Unique professional ID assigned by NPPES) is 1255041240. Ms. Genesis Marte has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Ms. Genesis Marte speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1255041240
NPI Enumeration Date:
30 Nov, 2022
NPI Last Update On:
23 Jul, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ms. Genesis Marte are as mentioned below.
License Number
Specialization
State
Status
357253
Family
New York
Primary
777822
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Ms. Genesis Marte 3548 Tryon Ave Apt 4c, Bronx, New York
Zip:
10467-1567
Phone Number:
347-453-7672
Patients can reach Ms. Genesis Marte at 3548 Tryon Ave, Bronx, New York or can call to book an appointment on 347-453-7672.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.